Ingredient ID 867 
Chinese Pronunciation QINGMENGSHI 
English Name Biotite Schist And Mia Carbonate Schist By Chloritization  
Latin Name Lapis Chloriti  
Aliases MengShi  
Cancers  
Identified Compounds
10

order by name

1. Caco3

   CCaO3   100.09
  ID:6889

2. Ca2(al,fe3+)3[sio4]3(oh)

      

3. Camg

      

4. Camg[co3]2

      

5. Ca[al2si2o8]

      

6. K(mg,fe2+)3[(al,fe3+)si3o10](oh,f)2

      

7. Kal2[alsi3o10](oh)2

      

8. Kmg3[alsi3o10](oh,f)2

      

9. Na[alsi3o8]

      

10. Sio2

      

 
Recipes that contain
QINGMENGSHI
  1. 229      BanXiaZuRuTang
 

Available references (order by impact factor):

1:  Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
Growth inhibition of mouse MXT mammary tumor by the luteinizing hormone-releasing hormone antagonist SB-75.
J Natl Cancer Inst.    impact factor:   12.945
1990;  82(6): 513-7

2:  Lee TJ, Carney CN, Lapis JL, Higgins T, Fallon HJ.
Diphenylhydantoin-induced hepatic necrosis. A case study.
Gastroenterology.    impact factor:   12.182
1976;  70(3): 422-4

3:  Takacs L, Szende B, Monostori E, Rot A, Lapis K, Szecseny A, Ando I.
Expression of HLA-DR antigens on bileduct cells of rejected liver transplant.
Lancet.    impact factor:   10.197
1983;  2(8365-66): 1500

4:  Lapis JL, Orlando RC, Mittelstaedt CA, Staab EV.
Ultrasonography in the diagnosis of obstructive jaundice.
Ann Intern Med.    impact factor:   10.097
1978;  89(1): 61-3

5:  Szende B, Srkalovic G, Groot K, Lapis K, Schally AV.
Regression of nitrosamine-induced pancreatic cancers in hamsters treated with luteinizing hormone-releasing hormone antagonists or agonists.
Cancer Res.    impact factor:   8.614
1990;  50(12): 3716-21

6:  Cory JG, Halley MC, Jeney A, Lapis K.
5-Hexyl-2'-deoxyuridine blocks the cytotoxic effects of 5-fluorodeoxyuridine or deoxyadenosine in leukemia L1210 cells in culture.
Cancer Res.    impact factor:   8.614
1990;  50(15): 4552-6

7:  Tricot GJ, Jayaram HN, Lapis E, Natsumeda Y, Nichols CR, Kneebone P, Heerema N, Weber G, Hoffman R.
Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Cancer Res.    impact factor:   8.614
1989;  49(13): 3696-701

8:  Tricot GJ, Jayaram HN, Nichols CR, Pennington K, Lapis E, Weber G, Hoffman R.
Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.
Cancer Res.    impact factor:   8.614
1987;  47(18): 4988-91

9:  Kovalszky I, Jeney A, Asbot R, Lapis K.
Biochemistry and enzyme induction in MC-29 virus-induced transplantable avian hepatoma.
Cancer Res.    impact factor:   8.614
1976;  36(7 PT 1): 2140-5

10:  Lapis K, Beard D, Beard JW.
Transplantation of hepatomas induced in the avian liver by MC29 leukosis virus.
Cancer Res.    impact factor:   8.614
1975;  35(1): 132-8

11:  Beard JW, Hillman EA, Beard D, Lapis K, Heine U.
Neoplastic response of the avian liver to host infection with strain Mc29 leukosis verus.
Cancer Res.    impact factor:   8.614
1975;  35(7): 1603-27

12:  Langlois AJ, Lapis K, Ishizaki R, Beard JW, Bolognesi DP.
Isolation of a transplantable cell line induced by the MC29 avian leukosis virus.
Cancer Res.    impact factor:   8.614
1974;  34(6): 1457-64

13:  Lapis K, Benedeczky I.
Ultrastructural alterations caused by cytostatic sugar-alcohol derivatives.
Cancer Res.    impact factor:   8.614
1968;  28(7): 1256-74

14:  Lapis K, Benedeczky I.
Electron microscopic study of the shay chloroleukemia.
Cancer Res.    impact factor:   8.614
1967;  27(9): 1544-64

15:  Lapis SF, Harrison JH.
Selective chemical modification of porcine heart mitochondrial malic enzyme with 4,4'-bis(dimethylamino)diphenylcarbinol.
J Biol Chem.    impact factor:   7.666
1978;  253(20): 7476-81

16:  Lapis K, Bocsi J, Lapis P, Thorgeirsson UP.
Flow cytometric DNA-ploidy and proliferative activity of diethylnitrosamine-induced hepatocellular carcinoma and pulmonary metastases in monkeys.
Hepatology.    impact factor:   7.344
1995;  22(3): 952-61

17:  Nagy P, Schaff Z, Lapis K.
Immunohistochemical detection of transforming growth factor-beta 1 in fibrotic liver diseases.
Hepatology.    impact factor:   7.344
1991;  14(2): 269-73

18:  Paku S, Lapis K.
Morphological aspects of angiogenesis in experimental liver metastases.
Am J Pathol.    impact factor:   6.436
1993;  143(3): 926-36

19:  Timar J, Ladanyi A, Lapis K, Moczar M.
Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential.
Am J Pathol.    impact factor:   6.436
1992;  141(2): 467-74

20:  Timar J, Lapis K, Dudas J, Sebestyen A, Kopper L, Kovalszky I.
Proteoglycans and tumor progression: Janus-faced molecules with contradictory functions in cancer.
Semin Cancer Biol.    impact factor:   6.205
2002;  12(3): 173-86

21:  Lapis K, Timar J.
Role of elastin-matrix interactions in tumor progression.
Semin Cancer Biol.    impact factor:   6.205
2002;  12(3): 209-17

22:  Lapis K, Sarosi I, Bocsi J, Thorgeirsson UP.
Cytokeratin patterns of liver carcinomas induced by diethylnitrosamine in monkeys.
Lab Invest.    impact factor:   4.53
1995;  72(6): 748-59

23:  Zalatnai A, Lapis K, Szende B, Raso E, Telekes A, Resetar A, Hidvegi M.
Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats.
Carcinogenesis.    impact factor:   4.118
2001;  22(10): 1649-52

24:  Lapis K, Zalatnai A, Timar F, Thorgeirsson UP.
Quantitative evaluation of lysozyme- and CD68-positive Kupffer cells in diethylnitrosamine-induced hepatocellular carcinomas in monkeys.
Carcinogenesis.    impact factor:   4.118
1995;  16(12): 3083-5

25:  Raso E, Timar J, Paku S, Lapis K.
Metastasizing rat nephroblastoma. A rodent Wilms' tumour model.
Carcinogenesis.    impact factor:   4.118
1994;  15(6): 1243-9

26:  Kovalszky I, Szeberenyi S, Zalatnai A, Vincze I, Lapis K, Jeney A.
Modification of DENA-induced hepatocarcinogenesis by CCl4 cirrhosis. Comparison of the marker enzyme patterns.
Carcinogenesis.    impact factor:   4.118
1992;  13(5): 773-8

27:  Raso E, Timar J, Lapis K.
Development and characterization of a sex-dependent metastatic preputial gland adenocarcinoma in human tumor-bearing immunosuppressed F344 rats.
Carcinogenesis.    impact factor:   4.118
1992;  13(7): 1281-4

28:  Janossy L, Zalatnai A, Lapis K.
Quantitative light microscopic study on the distribution of Kupffer cells during chemical hepatocarcinogenesis in the rat.
Carcinogenesis.    impact factor:   4.118
1986;  7(8): 1365-9

29:  Suli-Vargha H, Jeney A, Lapis K, Medzihradszky K.
Synthesis and antitumor activity of N-terminal proline-containing peptide-(chloroethyl)nitrosoureas.
J Med Chem.    impact factor:   4.079
1987;  30(3): 583-6

30:  Lapis K, Bocsi J, Timar F, Lapis P, Thorgeirsson UP.
Studies on the proliferative activity of diethylnitrosamine-induced hepatocellular carcinomas in monkeys.
J Pathol.    impact factor:   3.833
1997;  181(4): 439-43

31:  Kovacs L, Szende B, Elek G, Lapis K, Horvath O, Hiszek I, Tamasi A, Schmidt O.
Working experience with a new vacuum-accelerated microwave histoprocessor.
J Pathol.    impact factor:   3.833
1996;  180(1): 106-10

32:  Meszaros K, Antoni F, Hrabak A, Szikla C, Garzo T, Tompa A, Lapis K.
Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
FEBS Lett.    impact factor:   3.72
1973;  35(1): 1-3

33:  Szende B, Srkalovic G, Schally AV, Lapis K, Groot K.
Inhibitory effects of analogs of luteinizing hormone-releasing hormone and somatostatin on pancreatic cancers in hamsters. Events that accompany tumor regression.
Cancer.    impact factor:   3.632
1990;  65(10): 2279-90

34:  Tovari J, Paku S, Raso E, Pogany G, Kovalszky I, Ladanyi A, Lapis K, Timar J.
Role of sinusoidal heparan sulfate proteoglycan in liver metastasis formation.
Int J Cancer.    impact factor:   3.545
1997;  71(5): 825-31

35:  Timar J, Diczhazi C, Bartha I, Pogany G, Paku S, Raso E, Tovari J, Ladanyi A, Lapis K, Kopper L, et al.
Modulation of heparan-sulphate/chondroitin-sulphate ratio by glycosaminoglycan biosynthesis inhibitors affects liver metastatic potential of tumor cells.
Int J Cancer.    impact factor:   3.545
1995;  62(6): 755-61

36:  Jayaram HN, Lapis E, Tricot G, Kneebone P, Paulik E, Zhen W, Engeler GP, Hoffman R, Weber G.
Clinical pharmacokinetic study of tiazofurin administered as a 1-hour infusion.
Int J Cancer.    impact factor:   3.545
1992;  51(2): 182-8

37:  Szepeshazi K, Lapis K, Schally AV.
Effect of combination treatment with analogs of luteinizing hormone-releasing hormone (LH-RH) or somatostatin and 5-fluorouracil on pancreatic cancer in hamsters.
Int J Cancer.    impact factor:   3.545
1991;  49(2): 260-6

38:  Ladanyi A, Timar J, Paku S, Molnar G, Lapis K.
Selection and characterization of human melanoma lines with different liver-colonizing capacity.
Int J Cancer.    impact factor:   3.545
1990;  46(3): 456-61

39:  Podmaniczky E, Szende B, Lapis K, Ferenc G.
Cell surface changes observed in MC-29 virus-infected chicken-embryo fibroblast (CEC) cultures.
Int J Cancer.    impact factor:   3.545
1976;  18(4): 536-9

40:  Schaff Z, Lapis K, Grimley PM.
Undulating membraneous structures associated with the endoplasmic reticulum in tumour cells.
Int J Cancer.    impact factor:   3.545
1976;  18(5): 697-702

41:  Jeney A, Kovalszky I, Raso E, Durand RE, Furesz J, Lapis K.
The biological activity of cisplatin and dibromodulcitol in combination therapy.
Br J Cancer.    impact factor:   3.282
1995;  71(2): 317-21

42:  Elek G, Lapis K, Rockenbauer A.
ESR investigation of paraffin-embedded ocular melanomas.
Br J Cancer.    impact factor:   3.282
1980;  41(2): 199-203

43:  Kovalszky I, Pogany G, Molnar G, Jeney A, Lapis K, Karacsonyi S, Szecseny A, Iozzo RV.
Altered glycosaminoglycan composition in reactive and neoplastic human liver.
Biochem Biophys Res Commun.    impact factor:   3.161
1990;  167(3): 883-90

44:  Szepeshazi K, Korkut E, Szende B, Lapis K, Schally AV.
Histological changes in Dunning prostate tumors and testes of rats treated with LH-RH antagonist SB-75.
Prostate.    impact factor:   3.037
1991;  18(3): 255-70

45:  Kopper L, Bankfalvi A, Mihalik R, Paloczi K, Benczur M, Lapis K.
Phenotypic characteristics of three human non-Hodgkin lymphoma lines: flow cytometric analysis after long-term maintenance.
Clin Exp Immunol.    impact factor:   2.831
1988;  74(2): 295-9

46:  Ladanyi A, Timar J, Lapis K.
Effect of lentinan on macrophage cytotoxicity against metastatic tumor cells.
Cancer Immunol Immunother.    impact factor:   2.82
1993;  36(2): 123-6

47:  Denes L, Szende B, Hajos G, Szporny L, Lapis K.
Selective restoration of immunosuppressive effect of cytotoxic agents by thymopoietin fragments.
Cancer Immunol Immunother.    impact factor:   2.82
1990;  32(1): 51-4

48:  Divald A, Jeney A, Nagy JO, Timar F, Lapis K.
Modification of the inhibitory effects of CCl4 on phospholipid and protein biosynthesis by prostacyclin.
Biochem Pharmacol.    impact factor:   2.755
1990;  40(7): 1477-83

49:  Jeney A, Gyapay G, Lapis K, Szende B, Bursics L, Tyihak E.
Methylation-like reaction of [3H-methyl]-N-5-trimethyllysine (TML) to chromatin components.
Biochem Pharmacol.    impact factor:   2.755
1980;  29(20): 2729-32

50:  Szepeshazi K, Milovanovic S, Lapis K, Groot K, Schally AV.
Growth inhibition of estrogen independent MXT mouse mammary carcinomas in mice treated with an agonist or antagonist of LH-RH, an analog of somatostatin, or a combination.
Breast Cancer Res Treat.    impact factor:   2.72
1992;  21(3): 181-92

51:  Szende B, Lapis K, Redding TW, Srkalovic G, Schally AV.
Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin.
Breast Cancer Res Treat.    impact factor:   2.72
1989;  14(3): 307-14

52:  Timar J, Tovari J, Pogany G, Ladanyi A, Paku S, Rso E, Bocsi J, Jeney A, Lapis K.
The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.
Eur J Cancer.    impact factor:   2.537
1996;  32A(1): 152-9

53:  Szende B, Kendrey G, Lapis K, Roe FJ, Lee PN.
Accuracy of admission and clinical diagnosis of tumours as revealed by 2000 autopsies.
Eur J Cancer.    impact factor:   2.537
1996;  32A(7): 1102-8

54:  Kopper L, Van Hanh T, Lapis K, Timar J.
Increased take rate of human tumour xenografts after carragheenan treatment.
Eur J Cancer.    impact factor:   2.537
1980;  16(5): 671-8

55:  Kopper L, Jeney A, Takacs J, Benedeczky I, Dzurillay E, Lapis K.
Studies of the growth of an ascitic tumour. I. Cellular and subcellular changes during the tumour growth.
Eur J Cancer.    impact factor:   2.537
1978;  14(1): 59-73

56:  Kopper L, Jeney A, Lapis K, Torok M.
Studies of the growth of an ascitic tumour. II. A system to study the tumour-age dependent effect of antitumour agents.
Eur J Cancer.    impact factor:   2.537
1978;  14(1): 75-82

57:  Slowik F, Fazekas I, Balint K, Gazso L, Pasztor E, Czirjak S, Lapis K.
Intrasellar hamartoma associated with pituitary adenoma.
Acta Neuropathol (Berl).    impact factor:   2.446
1990;  80(3): 328-33

58:  Preston JF 3rd, Lapis E, Gander JE.
Isolation and partial characterization of the exocellular polysaccharides of Penicillium charlesii. 3. Heterogeneity in size and composition of high molecular weight exocellular polysaccharides.
Arch Biochem Biophys.    impact factor:   2.386
1969;  134(2): 324-34

59:  Preston JF 3rd, Lapis E, Westerhouse S, Gander JE.
Isolation and partial characterization of the exocellular polysaccharides of Penicillium charlesii. II. The occurrence of phosphate groups in high molecular weight polysaccharides.
Arch Biochem Biophys.    impact factor:   2.386
1969;  134(2): 316-23

60:  Santarelli P, Lanza GA, Biscione F, Natale A, Corsini G, Riccio C, Occhetta E, Rossi P, Gronda M, Makmur J, et al.
Effects of thrombolysis and atenolol or metoprolol on the signal-averaged electrocardiogram after acute myocardial infarction. Late Potentials Italian Study (LAPIS).
Am J Cardiol.    impact factor:   2.361
1993;  72(7): 525-31

61:  Seth A, Lapis P, Vande Woude GF, Papas T.
High-level expression vectors to synthesize unfused proteins in Escherichia coli.
Gene.    impact factor:   2.258
1986;  42(1): 49-57

62:  Major J, Szende B, Lapis K, Thesz Z.
Increased SCE inducibility by low doses of methylcholanthrene in lymphocytes obtained from patients with Down's disease.
Mutat Res.    impact factor:   2.107
1985;  149(1): 51-5

63:  Erdo SL, Lapis E.
Presence of GABA receptors in rat oviduct.
Neurosci Lett.    impact factor:   2.085
1982;  33(3): 275-9

64:  Jeney A, Kopper L, Nagy P, Lapis K, Suli-Vargha H, Medzihradszky K.
Antitumor action of N-(2-chloroethyl)-N-nitrosocarbamoyl derivatives of biologically active polypeptide hormone fragments.
Cancer Chemother Pharmacol.    impact factor:   2.081
1986;  16(2): 129-32

65:  Weber G, Yamaji Y, Olah E, Natsumeda Y, Jayaram HN, Lapis E, Zhen WN, Prajda N, Hoffman R, Tricot GJ.
Clinical and molecular impact of inhibition of IMP dehydrogenase activity by tiazofurin.
Adv Enzyme Regul.    impact factor:   2.068
1989;  28: 335-56

66:  Weber G, Jayaram HN, Lapis E, Natsumeda Y, Yamada Y, Yamaji Y, Tricot GJ, Hoffman R.
Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia.
Adv Enzyme Regul.    impact factor:   2.068
1988;  27: 405-33

67:  Erdo SL, Lapis E.
Bicuculline-sensitive GABA receptors in rat ovary.
Eur J Pharmacol.    impact factor:   2.047
1982;  85(2): 243-6

68:  Lapis K, Radnot M.
Surface properties of human melanoma cells.
Am J Ophthalmol.    impact factor:   2.012
1971;  71(3): 740-50

69:  Cory JG, Downes DL, Ng CY, Belt JA.
5-hexyl-2'-deoxyuridine inhibition of nucleoside transport in L1210 cells.
Oncol Res.    impact factor:   1.992
1992;  4(4-5): 175-9

70:  Pogany G, Moczar E, Jeney A, Timar J, Timar F, Ditroi K, Lapis K.
Comparative study on Lewis lung tumour lines with 'low' and 'high' metastatic capacity. III. Glycosaminoglycan synthesis, transport and degradation in cell lines.
Clin Exp Metastasis.    impact factor:   1.845
1989;  7(6): 659-69

71:  Paku S, Rot A, Ladanyi A, Lapis K.
Demonstration of the organ preference of liver selected 'high metastatic' Lewis lung tumor cell line.
Clin Exp Metastasis.    impact factor:   1.845
1989;  7(6): 599-607

72:  Lapis K, Paku S, Liotta LA.
Endothelialization of embolized tumor cells during metastasis formation.
Clin Exp Metastasis.    impact factor:   1.845
1988;  6(1): 73-89

73:  Timar J, Moczar E, Timar F, Pal K, Kopper L, Lapis K, Jeney A.
Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. II. Cytochemical and biochemical evidence for differences in glycosaminoglycans.
Clin Exp Metastasis.    impact factor:   1.845
1987;  5(1): 79-87

74:  Pal K, Kopper L, Lapis K.
Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor.
Clin Exp Metastasis.    impact factor:   1.845
1983;  1(4): 341-7

75:  Tyihak E, Szende B, Lapis K.
Biological significance of methylated derivatives of lysine and arginine.
Life Sci.    impact factor:   1.774
1977;  20(3): 385-92

76:  Boros LG, Lapis K, Szende B, Tomoskozi-Farkas R, Balogh A, Boren J, Marin S, Cascante M, Hidvegi M.
Wheat germ extract decreases glucose uptake and RNA ribose formation but increases fatty acid synthesis in MIA pancreatic adenocarcinoma cells.
Pancreas.    impact factor:   1.685
2001;  23(2): 141-7

77:  Timar J, Lapis K.
Immunoelectron microscopy of human retroviruses.
Histol Histopathol.    impact factor:   1.601
1989;  4(3): 381-95

78:  Timar J, Nagy K, Lapis K.
Morphologic and immunoelectronmicroscopic identification of human T-cell lymphotropic virus type III (HTLV-III).
Histol Histopathol.    impact factor:   1.601
1986;  1(1): 43-7

79:  Zalatnai A, Lapis K.
Decreased hepatocarcinogenic effect of diethylnitrosamine in experimentally induced liver cirrhosis in rat: delay or inhibition?
Cancer Lett.    impact factor:   1.518
1994;  79(1): 1-7

80:  Zalatnai A, Sarosi I, Rot A, Lapis K, Lapsis K.
Inhibitory and promoting effects of carbon tetrachloride-induced liver cirrhosis on the diethylnitrosamine hepatocarcinogenesis in rats.
Cancer Lett.    impact factor:   1.518
1991;  57(1): 67-73

81:  Suli-Vargha H, Jeney A, Kopper L, Olah J, Lapis K, Botyanszki J, Csukas I, Gyovari B, Medzihradszky K.
Investigations on the antitumor effect and mutagenicity of alpha-MSH fragments containing melphalan.
Cancer Lett.    impact factor:   1.518
1990;  54(3): 157-62

82:  Nizze H, Lapis K, Kovacs L.
Allyl alcohol-induced changes in the rat exocrine pancreas.
Digestion.    impact factor:   1.442
1979;  19(6): 359-69

83:  Hidvegi M, Raso E, Tomoskozi Farkas R, Lapis K, Szende B.
Effect of MSC on the immune response of mice.
Immunopharmacology.    impact factor:   1.43
1999;  41(3): 183-6

84:  Repassy G, Schaff Z, Lapis K, Marton T, Jakab F, Sugar I.
Mucosa of the Heister valve in cholelithiasis: transmission and scanning electron microscopic study.
Arch Pathol Lab Med.    impact factor:   1.417
1978;  102(8): 403-5

85:  Ladanyi A, Timar J, Bocsi J, Tovari J, Lapis K.
Sex-dependent liver metastasis of human melanoma lines in SCID mice.
Melanoma Res.    impact factor:   1.414
1995;  5(2): 83-6

86:  Korenyi-Both A, Szobor A, Lapis K, Szathmary I.
Fine structural studies in myasthenia gravis. II. Lesions of the neuromuscular junction.
Eur Neurol.    impact factor:   1.379
1973;  10(5): 311-23

87:  Korenyi-Both A, Szobor A, Lapis K, Szathmary I, Kerpel-Fronius S.
Fine structural studies in myasthenia gravis. I. Muscle fibre lesions.
Eur Neurol.    impact factor:   1.379
1973;  10(4): 215-36

88:  Bocsi J, Berczi C, Balazs G, Lapis K.
Flow cytometric studies on the relationship between DNA content and clinicopathologic features of pancreatic cancers.
Anticancer Res.    impact factor:   1.375
1998;  18(3A): 1839-43

89:  Hidvegi M, Raso E, Tomoskozi-Farkas R, Paku S, Lapis K, Szende B.
Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Anticancer Res.    impact factor:   1.375
1998;  18(4A): 2353-8

90:  Lapis KY, Bocsi J, Tovari J, Bartha I, Timar J, Raso E.
Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts.
Anticancer Res.    impact factor:   1.375
1996;  16(6A): 3323-31

91:  Tovari J, Bocsi J, Ladanyi A, Lapis K, Timar J.
The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
Anticancer Res.    impact factor:   1.375
1996;  16(6A): 3307-12

92:  Raso E, Timar J, Lapis K.
Inhibition of the progression of human and rat Wilms' tumor by Tiazofurin.
Anticancer Res.    impact factor:   1.375
1996;  16(6A): 3333-9

93:  Timar J, Diczhazi C, Bartha, Ladanyi A, Tarcsafalvi A, Lapis K.
PMA induces shift from chondroitin to heparan sulphate on proteoglycans correlating with fibronectin adhesion of MDS human leukemia cells.
Anticancer Res.    impact factor:   1.375
1994;  14(3A): 1227-31

94:  Pogany G, Raso E, Peterszegi G, Keresztfalvi M, Lapis K, Jeney A.
Alterations in nucleoside monophosphate concentrations in 3LL tumours after combined treatment with tiazofurin and 5-hexyl-2'-deoxyuridine.
Anticancer Res.    impact factor:   1.375
1992;  12(1): 281-4

95:  Timar J, Lapis K.
Flow cytometric analysis of proteoglycan expression on murine tumor cells with different metastatic capacity.
Anticancer Res.    impact factor:   1.375
1990;  10(3): 785-7

96:  Nagy P, Kopper L, Gyapay G, Peterfy F, Lapis K.
Effect of interferon-alpha (IFN alpha) on various human tumor xenografts.
Anticancer Res.    impact factor:   1.375
1988;  8(3): 467-9

97:  Kopper L, Nagy P, Revesz T, Major J, Magyarosy E, Lapis K.
Transplantable human non-Hodgkin lymphoma line in artificially immunesuppressed mice.
Anticancer Res.    impact factor:   1.375
1987;  7(2): 193-8

98:  Jeney A, Kopper L, Lapis K, Vidra L, Institoris L.
Antitumour action of 1,5-dihalogeno-, and 1, 2-4, 5-dianhydro-xylitol derivatives.
Anticancer Res.    impact factor:   1.375
1984;  4(1-2): 23-5

99:  Kopper L, Lapis K, Csanyi E, Horvath T.
Effect of a new bifunctional nitrosoureido derivative on human colorectal tumor xenografts.
Anticancer Res.    impact factor:   1.375
1981;  1(4): 229-33

100:  Szende B, Lapis K, Jeney A, Simon K, Ordog A, Moldvay J.
Liver damaging effect of suramin in normal and carbon-tetrachloride treated rats.
Toxicol Pathol.    impact factor:   1.31
1991;  19(3): 266-72

101:  Gyure LA, Hall JG, Lapis K, Timar J.
The relief of biliary obstruction in experimental rats by diverting the hepatic lymph into the duodenum.
Int J Exp Pathol.    impact factor:   1.216
1991;  72(3): 345-8

102:  Timar J, Boldog F, Kopper L, Lapis K.
Flow cytometric measurements and electron microscopy of cell surface glycosaminoglycans using acridine orange.
Histochem J.    impact factor:   1.161
1985;  17(1): 71-9

103:  Denes L, Hajos G, Szporny L, Szende B, Lapis K, Sipka S, Szegedi G.
The effect of thymopoietin 32-34 (TP3) on suramin-induced inhibition on delayed type hypersensitivity in guinea pigs.
Immunol Invest.    impact factor:   1.084
1987;  16(4): 275-9

104:  Preston JF 3rd, Lapis E, Gander JE.
Immunological investigations of Penicillium. I. Serological reactivities of exocellular polysaccharides produced by six Penicillium species.
Can J Microbiol.    impact factor:   1.072
1970;  16(8): 687-94

105:  Szende B, Kendrey G, Lapis K, Lee PN, Roe FJ.
Accuracy of admission and pre-autopsy clinical diagnoses in the light of autopsy findings: a study conducted in Budapest.
Hum Exp Toxicol.    impact factor:   1.063
1994;  13(10): 671-80

106:  Timar J, Pogany G, Balazs M, Szollosi J, Ladanyi A, Olah J, Timar F, Lapis K, Jeney A.
Modulation of membrane phenotype, matrix adhesion and microinvasiveness of metastatic tumour cells by HUdR.
Cell Biochem Funct.    impact factor:   1.014
1990;  8(4): 211-20

107:  Szende B, Juhasz E, Lapis K, Schally AV.
Inhibition of two-step urinary bladder carcinogenesis by the somatostatin analogue RC-160.
Urol Res.    impact factor:   .993
1992;  20(6): 383-6

108:  Hidvegi M, Raso E, Tomoskozi-Farkas R, Szende B, Paku S, Pronai L, Bocsi J, Lapis K.
MSC, a new benzoquinone-containing natural product with antimetastatic effect.
Cancer Biother Radiopharm.    impact factor:   .989
1999;  14(4): 277-89

109:  Caux F, Timar J, Lapis K, Moczar M.
Proteochondroitin sulphate in human melanoma cell cultures.
Biochem Soc Trans.    impact factor:   .975
1990;  18(2): 293-4

110:  Timar J, Ladanyi A, Moczar M, Lapis K, Moczar E.
Heparin-binding proteins from human melanoma cells.
Biochem Soc Trans.    impact factor:   .975
1990;  18(3): 495-6

111:  Caux F, Timar J, Moczar E, Lapis K, Moczar M.
Cell-associated glycosaminoglycans in human melanoma cell culture.
Biochem Soc Trans.    impact factor:   .975
1990;  18(2): 294-5

112:  Schaff Z, Eder G, Eder C, Lapis K.
Intracytoplasmic crystalline inclusions in the hepatocytes of humans and chimpanzees.
Ultrastruct Pathol.    impact factor:   .918
1990;  14(4): 303-9

113:  Schaff Z, Lapis K, Keresztury S, Kollath Z, Herics M, Hollos I.
Occurrence of tubuloreticular inclusions in acute viral hepatitis.
Ultrastruct Pathol.    impact factor:   .918
1982;  3(2): 169-73

114:  Lapis K.
The value of electron microscopy in diagnostic pathology. Case 7.
Ultrastruct Pathol.    impact factor:   .918
1980;  1(1): 105-9

115:  Levinson SL, Powell DW, Callahan WT, Jones JD, Kinard HB 3rd, Jackson AL, Lapis JL, Drossman DA.
A current approach to rectal bleeding.
J Clin Gastroenterol.    impact factor:   .916
1981;  3 Suppl 1: 9-16

116:  Kinard HB 3rd, Powell DW, Sandler RS, Callahan WT, Lapis JL, Levinson SL, Jones JD, Drossman DA, Jackson AL.
A current approach to acute upper gastrointestinal bleeding.
J Clin Gastroenterol.    impact factor:   .916
1981;  3(3): 231-40

117:  Denes L, Szende B, Hajos G, Szporny L, Lapis K.
Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
Drugs Exp Clin Res.    impact factor:   .897
1987;  13(5): 279-87

118:  Divald A, Ujhelyi E, Jeney A, Lapis K, Institoris L.
Hepatoprotective effects of prostacyclins on CCl4-induced liver injury in rats.
Exp Mol Pathol.    impact factor:   .846
1985;  42(2): 163-6

119:  Szende B, Lapis K, Kovalszky I, Timar F.
Role of the modified (glycosaminoglycan producing) perisinusoidal fibroblasts in the CCl4-induced fibrosis of the rat liver.
In Vivo.    impact factor:   .794
1992;  6(4): 355-61

120:  Lapis K.
Morphologic expression of neoplasia in human and experimental liver tumors.
Prog Clin Biol Res.    impact factor:   .782
1983;  132D: 67-76

121:  Szende B, Lapis K, Pal K, Sipos L, Denes L, Kisfaludy L.
The effect of TP-3 (Arg-Lys-Asp), TP-4 (Arg-Lys-Asp-Val), and TP-5 on the metastatic capacity of intravenously injected Lewis lung tumor cells.
Immunopharmacol Immunotoxicol.    impact factor:   .761
1987;  9(1): 19-24

122:  Denes L, Szende B, Ember J, Major J, Szporny L, Hajos G, Nyeki O, Schon I, Lapis K, Kisfaludy L.
Immunoregulating peptides II. In vitro effects of TP5 analogs on E-rosette formation and cell division.
Immunopharmacol Immunotoxicol.    impact factor:   .761
1987;  9(1): 1-18

123:  Zalatnai A, Lapis K, Feher I.
The nucleolar organizer regions in hyperplastic and tumorous lesions of the human liver.
Pathol Res Pract.    impact factor:   .729
1993;  189(5): 536-41

124:  Kopper L, Lapis K.
What's new in macrophage-tumor cell interaction?
Pathol Res Pract.    impact factor:   .729
1985;  179(6): 652-5

125:  Lapis K.
Retroperitoneal giant lymph node hyperplasia (plasmocytic type).
Pathol Res Pract.    impact factor:   .729
1985;  180(2): 209-13

126:  Timar J, Kopper L, Pal K, Lapis K.
Transmission and scanning-electronmicroscopy of experimental liver metastases derived from intrasplenically growing primary tumor.
Pathol Res Pract.    impact factor:   .729
1983;  177(1): 47-59

127:  Miklaszewicz A, Giedrys-Kalemba S, Teodorczyk U, Halasa J, Goertz K, Zielinski S, Ostrowski M, Kostyrka R, Lapis J, Kulig G, Kulig T, Kruszewski T, Kozlowski M, Lewinski D, Grzywacz B, Grzywacz M, Kuprjanowicz L.
Influence of protective genes in the HLA system on renal graft survival.
Transplant Proc.    impact factor:   .678
2000;  32(6): 1337-8

128:  Timar J, Moczar M, Lapis K, Moczar E.
Interactions of exogenous heparan sulfate with tumor cells of different metastatic phenotype.
Invasion Metastasis.    impact factor:   .677
1990;  10(5): 301-15

129:  Pal K, Kopper L, Timar J, Rajnai J, Lapis K.
Comparative study on Lewis lung tumor lines with 'low' and 'high' metastatic capacity. I. Growth rate, morphology and resistance to host defence.
Invasion Metastasis.    impact factor:   .677
1985;  5(3): 159-69

130:  Pal K, Kopper L, Lapis K.
Increased metastatic capacity of Lewis lung tumor cells by in vivo selection procedure.
Invasion Metastasis.    impact factor:   .677
1983;  3(3): 174-82

131:  Borzsonyi M, Lapis K, Varga L, Varteresz V.
Study on the effect of dibromodulcitol (1,6-dibromo-1,6-dideoxydulcitol) on the desoxy-ribonucleic acid metabolism of NK-Ly ascites tumour cells with an autoradiographic method.
Arzneimittelforschung.    impact factor:   .671
1969;  19(4): 669-71

132:  Borzsonyi M, Lapis K, Varga L, Varteresz V.
[Autoradiographic studies of the effect of the cytostatic 1,4-bis-(2'-mesyloxyethylamino)-1,4-didesoxymesoerythritol on desoxyribonucleic acid metabolism in NK-Ly-ascites tumor cells]
Arzneimittelforschung.    impact factor:   .671
1967;  17(12): 1596-8

133:  Zalatnai A, Lapis K.
Simultaneous induction of liver cirrhosis and hepatocellular carcinomas in F-344 rats: establishment of a short hepatocarcinogenesis model.
Exp Toxicol Pathol.    impact factor:   .603
1994;  46(3): 215-22

134:  Herbst CA Jr, Sessions JT Jr, Lapis JL.
Fiberoptic colonoscopic examination in surgical patients with colorectal cancer.
South Med J.    impact factor:   .593
1980;  73(5): 548-50, 554

135:  Radnot M, Lapis K, Medgyaszay A.
[Ultrastructural examination of a malignant melanoma of the lacrimal sac]
Ophthalmologica.    impact factor:   .557
1971;  163(2): 73-89

136:  Radnot M, Lapis K.
Ultrastructure of the caruncular oncocytoma.
Ophthalmologica.    impact factor:   .557
1970;  161(1): 63-77

137:  Gyorfi T, Timar J, Lapis K.
Liver-metastatic human colon carcinoma in immunosuppressed mice.
Neoplasma.    impact factor:   .448
1991;  38(1): 49-55

138:  Kopper L, Lapis K, Schaff Z, Mihalik R, Karacsony S, Szecseny A.
Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma.
Neoplasma.    impact factor:   .448
1991;  38(3): 257-63

139:  Pogany G, Jeney A, Timar J, Major J, Lapis K.
Modulation of glycoconjugate biosynthesis by 5-hexyl-2'-deoxyuridine in highly metastatic Lewis lung carcinoma cells.
Neoplasma.    impact factor:   .448
1990;  37(5): 501-10

140:  Gyapay G, Jeney A, Lapis K.
Drug action and chromatin structure. I. Adriamycin binding to core particle of nucleosomes and subsequent enhanced DNA fragmentation induced by micrococcal nuclease.
Neoplasma.    impact factor:   .448
1985;  32(5): 521-8

141:  Furesz J, Pal K, Budavari I, Lapis K.
The physico-chemical properties of tumor cells with different metastatic potential.
Neoplasma.    impact factor:   .448
1985;  32(6): 689-94

142:  Szende B, Lapis K, Simon K.
Combined effect of cytostatic drugs and E-N-L-trimethyl lysine in healthy and transplantable tumor bearing mice.
Neoplasma.    impact factor:   .448
1982;  29(4): 427-39

143:  Suba Z, Szende B, Lapis K, Takacs J, Elek G.
epsilon-N-trimethyl-lysine: a natural cell component with mitogenic activity.
Neoplasma.    impact factor:   .448
1980;  27(1): 11-23

144:  Elek G, Karczag E, Foldes I, Jokay I, Lapis K.
Immunodiffusion analysis of the antigenic structure of the transplantable MC 29 tumor.
Neoplasma.    impact factor:   .448
1976;  23(3): 265-70

145:  Kopper L, Lapis K, Institoris L.
Incorporation of 3H-dibromodulcitol and 3H-dianhydrodulcitol into ascites tumor cells. Autoradiographic study.
Neoplasma.    impact factor:   .448
1976;  23(1): 47-52

146:  Stotz G, Sreter L, Lapis K.
Karyotype analysis of NK-Ly ascites lymphoma in mice by means of a reassociation technique.
Neoplasma.    impact factor:   .448
1974;  21(5): 545-9

147:  Kopper L, Kiss J, Lapis K.
Nucleolar alterations in ascites tumour cells induced by 5-fluorouracil treatment.
Neoplasma.    impact factor:   .448
1973;  20(3): 225-30

148:  Szende B, Tyihak E, Kopper L, Lapis K.
The tumour growth promoting effect of eta-N-trimethyl lysine.
Neoplasma.    impact factor:   .448
1970;  17(4): 433-4

149:  Borzsonyi M, Connors TA, Lapis K.
Enhancement of immune response by 1.6-dibromo-1.
Neoplasma.    impact factor:   .448
1969;  16(4): 393-6

150:  Lapis K, Elek G.
Effect of rat immune serum on the ultrastructure of ascites tumour-cells.
Neoplasma.    impact factor:   .448
1966;  13(3): 275-87

151:  Kopper L, Timar J, Jeney A, Lapis K.
Glycosaminoglycan (GAG) metabolism as a potential target to prevent metastasis formation.
Adv Exp Med Biol.    impact factor:   .446
1988;  233: 367-75

152:  Weinstein P, Lapis K.
[Ultrastructure of various types of glaucoma]
Klin Monatsbl Augenheilkd.    impact factor:   .406
1969;  155(1): 7-13

153:  Szilagyi G, Boga M, Rutkai P, Lapis K.
Complications of haemangiomatoses. Kasabach-Merritt syndrome in an adult.
Haematologia (Budap).    impact factor:   .405
1973;  7(1): 69-81

154:  Lapis K, Schuler D.
Effect of tetra-o-methyl-sulphonyl-D-mannitol (R-52) on the ultrastructure of lymphoid cells in tissue culture.
Haematologia (Budap).    impact factor:   .405
1971;  5(1): 5-23

155:  Forbes TR.
Lapis bufonis: the growth and decline of a medical superstition.
Yale J Biol Med.    impact factor:   .381
1972;  45(2): 139-49

156:  Lang I, Magyarosy E, Kopper L, Lapis K, Petranyi G.
Retroperitoneal plasmocytic giant lymph node hyperplasia.
J R Soc Med.    impact factor:   .27
1984;  77(6): 517-9

157:  Gyapay G, Lapis E, Jeney A, Lapis K.
Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH). II. Modification of cyclic adenosine-3',5'-monophosphate levels by catecholamines, glucagon and Vinca alkaloids in normal chicken liver and VTH.
Acta Biol Hung.    impact factor:   .219
1984;  35(1): 35-41

158:  Kovalszky I, Jeney A, Lapis K, Bencsath M.
Further studies on the biochemical characterization of the MC-29 virus derived transplantable hepatoma (VTH). I. Binding of 3H-cortisol to cytoplasmic receptor and DNA.
Acta Biol Hung.    impact factor:   .219
1984;  35(1): 27-34

159:  Gorgenui A, Lapis K, Borzsonyi M, Machay T, Schuler D.
[Some rare pulmonary complications in leukemic children during full haematological remission]
Monatsschr Kinderheilkd.    impact factor:   .14
1974;  122(10): 799-804

160:  Radnot M, Lapis K, Feher J.
Amyloid tumor in the lachrymal gland.
Ann Ophthalmol.    impact factor:   .126
1971;  3(7): 727-35 passim

161:  Berczi C, Bocsi J, Lapis K, Balazs G.
Relationship between the survival and the clinicopathological parameters of the patients with tumors in the pancreatic head region.
Acta Chir Hung.    impact factor:   0
1999;  38(3-4): 235-41

162:  Kovalszky I, Nagy P, Szende B, Lapis K, Szalay F, Jeney A, Schaff Z.
Experimental and human liver fibrogenesis.
Scand J Gastroenterol Suppl.    impact factor:   0
1998;  228: 51-5

163:  Schaff Z, Kovalszky I, Nagy P, Zalatnai A, Jeney A, Lapis K.
Human and experimental hepatocarcinogenesis.
Scand J Gastroenterol Suppl.    impact factor:   0
1998;  228: 90-7

164:  Szende B, Raso E, Hidvegi M, Tomoskozine FR, Paku S, Pronai L, Bocsi J, Lapis K.
[A new benzoquinone-containing antimetastatic product]
Orv Hetil.    impact factor:   0
1998;  139(48): 2893-7

165:  Berczi C, Bocsi J, Lapis K, Balazs G.
Effect of the DNA ploidity on survival in patients with carcinoma of papilla of Vater.
Acta Chir Hung.    impact factor:   0
1997;  36(1-4): 27-9

166:  Podanyi B, Lukacs G, Lapis K.
[Pulmonary tuberculosis revealed by lupus vulgaris]
Orv Hetil.    impact factor:   0
1996;  137(48): 2683-5

167:  Kovalszky I I, Schaff Z, Lapis K, Jeney A.
Marker Enzymes of Rat Chemical Hepatocarcinogenesis in Human Liver Tumors.
Pathol Oncol Res.    impact factor:   0
1996;  2(1-2): 56-58

168:  Kovacs L, Szende B, Elek G, Lapis K, Horvath O, Hiszek I, Tamasi A, Schmidt O.
[Experiences with a new vacuum-accelerated microwave histoprocessor]
Orv Hetil.    impact factor:   0
1996;  137(27): 1479-83

169:  Divald A, Gyorgydeak Z, Timar F, Zalatnai A, Bognar R, Horvath G, Lapis K, Jeney A.
Modification of Acute and Chronic Liver Damage by Thiazolidine Compounds.
Pathol Oncol Res.    impact factor:   0
1995;  1(1): 60-63

170:  Timar J, Diczhazi C, Ladanyi A, Raso E, Hornebeck W, Robert L, Lapis K.
Interaction of tumour cells with elastin and the metastatic phenotype.
Ciba Found Symp.    impact factor:   0
1995;  192: 321-35; discussion 335-7

171:  Kopper L, Lapis K, Schaff Z, Mihalik R.
Significance of cellular DNA content in human liver tumors.
Acta Biomed Ateneo Parmense.    impact factor:   0
1993;  64(5-6): 165-9

172:  Kovalszky I, Jeney A, Lapis K.
[Proteoglycans (their structure, function and role in liver diseases)]
Orv Hetil.    impact factor:   0
1993;  134(37): 2019-26

173:  Toth M, Molnar G, Schaff Z, Racz K, Kiss R, Futo L, Varga I, Glaz E, Lapis K.
[Flow-cytometric study of the DNA content in adrenal cortex tumors]
Orv Hetil.    impact factor:   0
1993;  134(26): 1411-5

174:  Lapis K.
[Prognostic value of cell proliferation markers in malignant tumor diseases]
Orv Hetil.    impact factor:   0
1992;  133(43): 2747-52

175:  Lapis P, Freeman J, Bitter MA, Golitz LE.
Absence of HTLV-I DNA sequences in cutaneous T-cell lymphoma/mycosis fungoides.
Acta Morphol Hung.    impact factor:   0
1992;  40(1-4): 249-55

176:  Schaff Z, Eder G, Eder C, Lapis K.
Ultrastructure of normal and hepatitis virus infected human and chimpanzee liver: similarities and differences.
Acta Morphol Hung.    impact factor:   0
1992;  40(1-4): 203-14

177:  Szende B, Schally AV, Lapis K.
Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours.
Acta Morphol Hung.    impact factor:   0
1991;  39(1): 53-8

178:  Schaff Z, Lapis K, Szende B, Jeney A, Gergely P, Simon K, Divald A, Timar F, Major J.
The effect of D-penicillamine on CCl4-induced experimental liver cirrhosis.
Exp Pathol.    impact factor:   0
1991;  43(1-2): 111-20

179:  Sarosi I, Kiss A, Schaff Z, Lapis K.
Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Acta Morphol Hung.    impact factor:   0
1991;  39(4): 321-31

180:  Timar J, Lapis K, Fulop T, Varga ZS, Tixier JM, Robert L, Hornebeck W.
Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies.
J Cancer Res Clin Oncol.    impact factor:   0
1991;  117(3): 232-8

181:  Kovalszky I, Kralovanszky J, Jeney A, Lapis K, Karacsonyi S, Szecheny A.
Alkaline phosphatase activity in human and rat liver tumors.
Oncology.    impact factor:   0
1991;  48(2): 144-8

182:  Sarosi I, Kiss A, Schaff Z, Lapis K.
Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
Acta Microbiol Hung.    impact factor:   0
1991;  39(4): 321-31

183:  Szende B, Srkalovic G, Timar J, Mulchahey JJ, Neill JD, Lapis K, Csikos A, Szepeshazi K, Schally AV.
Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells.
Proc Natl Acad Sci U S A.    impact factor:   0
1991;  88(10): 4153-6

184:  Szende B, Lapis K, Timar J, Antoni F, Csuka I.
Morphological studies on the effect of L-leucine methyl ester on mouse peritoneal macrophages in vitro.
Exp Pathol.    impact factor:   0
1991;  42(3): 121-7

185:  Schweighoffer T, Schweighoffer E, Apati A, Antoni F, Molnar G, Lapis K, Banfalvi G.
Cytometric analysis of DNA replication inhibited by emetine and cyclosporin A.
Histochemistry.    impact factor:   0
1991;  96(1): 93-7

186:  Besznyak I, Tasnadi G, Hirsch T, Koves I, Schaff Z, Lapis K.
[Hepato-lobectomy for carcinoid tumor of the hepatic duct]
Orv Hetil.    impact factor:   0
1991;  132(11): 591-4

187:  Schaff Z, Lapis K.
[The hepatitis C virus--principal causative agent in non-A, non-B hepatitis]
Orv Hetil.    impact factor:   0
1990;  131(35): 1903-6

188:  Lapis K, Schaff Z, Kopper L, Karacsonyi S, Ormos J.
[Fibrolamellar liver carcinoma]
Zentralbl Allg Pathol.    impact factor:   0
1990;  136(1-2): 135-49

189:  Paku S, Timar J, Lapis K.
Ultrastructure of invasion in different tissue types by Lewis lung tumour variants.
Virchows Arch A Pathol Anat Histopathol.    impact factor:   0
1990;  417(5): 435-42

190:  Lapis K, Timar J, Papay J, Paku S, Szende B, Ladanyi A.
Experimental metastasis inhibition by pretreatment of the host.
Arch Geschwulstforsch.    impact factor:   0
1990;  60(2): 97-102

191:  Timar J, Ladanyi A, Lapis K, Moczar E.
Galactosylated glycan expression and macrophage sensitivity of Lewis lung tumor cells with different metastatic phenotype.
J Cancer Res Clin Oncol.    impact factor:   0
1990;  116(3): 264-70

192:  Gagarinova VM, Alferov VP, Kuznetsov VP, Ostrovskaia SA, Lapis GA, Piskareva NA.
[Human leukocytic interferon as an agent for emergency prevention of influenza and other acute respiratory diseases in children's preschool institutions]
Pediatriia.    impact factor:   0
1990;  (11): 74-8

193:  Szende B, Jeney A, Lapis K.
Methylcellulose prevents the regression of carbon tetrachloride-induced liver fibrosis and cirrhosis in rats.
J Toxicol Environ Health.    impact factor:   0
1990;  29(1): 59-63

194:  Lapis K, Kavalsky I, Jeney A, Pogany G, Molnar G, Repassy D, Szecseny A, Karacsonyi S.
Alterations of glycosaminoglycans in human liver and kidney tumors.
Tokai J Exp Clin Med.    impact factor:   0
1990;  15(2-3): 155-65

195:  Lapis K, Papay J, Paku S.
Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice.
Oncology.    impact factor:   0
1990;  47(4): 359-64

196:  Jeney A, Timar J, Pogany G, Paku S, Moczar E, Mareel M, Otvos L, Kopper L, Lapis K.
Glycosaminoglycans as novel target in antitumor therapy.
Tokai J Exp Clin Med.    impact factor:   0
1990;  15(2-3): 167-77

197:  Olah E, Kote Z, Natsumeda Y, Yamaji Y, Jarai G, Lapis E, Financsek I, Weber G.
Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells.
Cancer Biochem Biophys.    impact factor:   0
1990;  11(2): 107-17

198:  Timar J, Kovalszky I, Paku S, Lapis K, Kopper L.
Two human melanoma xenografts with different metastatic capacity and glycosaminoglycan pattern.
J Cancer Res Clin Oncol.    impact factor:   0
1989;  115(6): 554-7

199:  Antoni F, Csuka I, Hrabak A, Temesi A, Szende B, Lapis K.
The effect of L-leucine methyl ester on the phagocytosis and amino acid incorporation of murine peritoneal cells.
Acta Biochim Biophys Hung.    impact factor:   0
1989;  24(4): 299-311

200:  Mandl J, Banhegyi G, Garzo T, Lapis K, Antoni F, Schaff Z.
Ethanol treatment inhibits the development of diethylnitrosamine-induced tumors in rats.
J Exp Pathol.    impact factor:   0
1989;  4(4): 227-35

201:  Lapis K.
[New trends and results in metastasis research]
Orv Hetil.    impact factor:   0
1988;  129(19): 975-83

202:  Szende B, Lapis K, Timar J, Schaff Z, Simon K, Jeney A, Divald A, Paku S, Timar F.
Glycosaminoglycan containing fat-storing cells in hepatic fibrogenesis.
Acta Morphol Hung.    impact factor:   0
1988;  36(3-4): 241-51

203:  Timar J, Smirnova EA, Lapis K.
[Electron microscopic immunohistochemistry in the diagnosis of human lymphotropic viral diseases]
Vopr Onkol.    impact factor:   0
1988;  34(12): 1439-42

204:  Watson DK, McWilliams MJ, Lapis P, Lautenberger JA, Schweinfest CW, Papas TS.
Mammalian ets-1 and ets-2 genes encode highly conserved proteins.
Proc Natl Acad Sci U S A.    impact factor:   0
1988;  85(21): 7862-6

205:  Auth F, Kiss B, Laszlovszky I, Lapis E.
Substituted ergolines: potential antipsychotics with unique profile. II. Neurochemical characterization.
Pol J Pharmacol Pharm.    impact factor:   0
1988;  40(6): 603-11

206:  Lapis J, Dziewanowski K.
[Intrarenal manometry of transplanted kidneys]
Wiad Lek.    impact factor:   0
1987;  40(20): 1379-82

207:  Szepeshazi K, Lapis K.
Striated microfilament bundles (SMF) in the glomerular cells of human kidneys.
Acta Morphol Hung.    impact factor:   0
1987;  35(1-2): 77-88

208:  Zalatnai A, Lapis K.
Diethyl-nitrosamine hepatocarcinogenesis in cirrhotic rats.
Acta Morphol Hung.    impact factor:   0
1987;  35(3-4): 211-8

209:  Lapis J, Switlik I, Uminski M, Zielinski S.
[Initial 2-year results of the treatment of patients after kidney transplantation at the Szczecin center]
Wiad Lek.    impact factor:   0
1987;  40(6): 428-31

210:  Rajnay J, Kopper L, Lapis K.
Chemotherapeutic response of squamous cell carcinoma xenografts (subcutaneous and subrenal capsule assay).
Oncology.    impact factor:   0
1987;  44(5): 307-11

211:  Schaff Z, Racz K, Gutkowska J, Sergev O, Kiss R, Varga I, Szabo Z, Szende B, Lapis K, Feher J, et al.
Immunohistochemical localization of atrial natriuretic peptide in primary aldosteronism.
J Exp Pathol.    impact factor:   0
1987;  3(3): 229-42

212:  Aszalos A, Grof P, Fidy J, Hajdu O, Pal K, Jeney A, Lapis K.
Comparison of biophysical parameters of primary low and high metastatic Lewis lung tumor cells.
J Med.    impact factor:   0
1986;  17(3-4): 179-200

213:  Jeney A, Barrie SE, Taylor GA, Newell DR, Harrap KR, Szabolcs A, Lapis K, Otvos L.
5-Ethyl-2'-deoxyuridine: an explanation for its lack of cytotoxic action in vivo.
Eur J Cancer Clin Oncol.    impact factor:   0
1986;  22(5): 557-62

214:  Vajta G, Divald A, Paku S, Elek J, Lapis K.
Fatty degeneration in cultured hepatocytes. A new experimental model.
Virchows Arch B Cell Pathol Incl Mol Pathol.    impact factor:   0
1986;  52(2): 177-84

215:  Schaff Z, Seto B, Coleman WG Jr, Lapis K.
Morphology and immunohistochemistry of experimental and human non-A, non-B hepatitis.
Tokai J Exp Clin Med.    impact factor:   0
1986;  11 Suppl: 111-20

216:  Lapis K, Jeney A, Divald A, Vajta G, Zalatnai A, Schaff Z.
Experimental studies on the effect of hepatoprotective compounds.
Tokai J Exp Clin Med.    impact factor:   0
1986;  11 Suppl: 135-45

217:  Lapis P, Kopper L, Bodrogi I, Sugar J, Lapis K, Eckhardt S.
Characteristics and chemotherapeutic sensitivity of a human testicular cancer grown in artificially immunosuppressed mice.
Oncology.    impact factor:   0
1985;  42(2): 112-8

218:  Szendroi M, Lapis K.
Distribution of fibronectin and laminin in human liver tumors.
J Cancer Res Clin Oncol.    impact factor:   0
1985;  109(1): 60-4

219:  Szendroi M, Lapis K.
Fibronectin in differential diagnosis of primary hepatomas and carcinoma metastases in the liver.
Acta Morphol Hung.    impact factor:   0
1985;  33(1-2): 101-9

220:  Dziewanowski K, Lapis J.
[Tonometry of the transplanted kidney]
Wiad Lek.    impact factor:   0
1985;  38(23): 1637-40

221:  Jeney A, Lapis K.
[The role of A. Haddow and the Chester Beatty Institute of the Royal Cancer Hospital in tumor research 1950-1960]
Orv Hetil.    impact factor:   0
1985;  126(20): 1237-8

222:  Szende B, Kisfaludy L, Lapis K, Denes L, Szporny L, Nyeke O, Schon I, Hajos G, Ember J, Constantin M, et al.
The effect of TP-5 and its analogs on skin grafts in mice.
J Immunopharmacol.    impact factor:   0
1985;  7(1): 67-78

223:  Szecseny A, Faller J, Lapis K, Schaff Z.
[Focal nodular hyperplasia of great extent in the liver after taking oral contraceptives]
Orv Hetil.    impact factor:   0
1984;  125(12): 687-91

224:  Pande H.
[Avoid water in the neonate's eyes. Practical realization and experiences after 1 1/2 years' cessation of Crede lapis prophylaxis]
Tidsskr Nor Laegeforen.    impact factor:   0
1984;  104(15): 1065-7

225:  Pande H.
[Crede lapis prophylaxis in the newborn infant. A prospective 1980-1981 study of 1195 infants]
Tidsskr Nor Laegeforen.    impact factor:   0
1984;  104(15): 1067-9

226:  Schaff Z, Lapis K, Szendroi M.
D-galactosamine-induced liver injury in immunosuppressed mice.
Acta Morphol Hung.    impact factor:   0
1984;  32(1): 67-72

227:  Szendroi M, Lapis K, Zalatnai A, Robert L, Labat-Robert J.
Appearance of fibronectin in putative preneoplastic lesions and in hepatocellular carcinoma during chemical hepatocarcinogenesis in rats and in human hepatomas.
J Exp Pathol.    impact factor:   0
1984;  1(3): 189-99

228:  Lapis K, Ujhelyi E, Gyenes M, Jeney A.
Alterations of markers during hepatocarcinogenesis in rats.
IARC Sci Publ.    impact factor:   0
1984;  (56): 25-36

229:  Kopper L, Magyarosy E, Jeney A, Lapis K, Szabolcs A, Otvos L.
Potentiation of the antitumor action of 5-fluorouracil with 5-ethyl-2'-deoxyuridine in human colorectal tumor xenografts.
Oncology.    impact factor:   0
1984;  41(3): 155-8

230:  Ujhelyi E, Divald A, Vajta G, Jeney A, Lapis K.
Effect of PGI2 in carbon tetrachloride-induced liver injury.
Acta Physiol Hung.    impact factor:   0
1984;  64(3-4): 425-30

231:  Szendroi M, Vajta G, Kovacs L, Schaff Z, Lapis K.
Polarization colours of collagen fibres: a sign of collagen production activity in fibrotic processes.
Acta Morphol Hung.    impact factor:   0
1984;  32(1): 47-55

232:  Csaszar A, Lapis K.
Diffuse rheumatoid nodules in skeletal muscle in rheumatoid arthritis.
Acta Morphol Hung.    impact factor:   0
1984;  32(2): 127-32

233:  Simon K, Lapis K.
Carcinogenesis studies on guppies.
Natl Cancer Inst Monogr.    impact factor:   0
1984;  65: 71-81

234:  Kopper L, Magyarosy E, Nagy P, Lapis K, Szamel I, Eckhardt S, Csata S, Wabrosch G, Repassy D.
Renal cell carcinoma--xenotransplantation into immuno-suppressed mice.
Oncology.    impact factor:   0
1984;  41(1): 19-24

235:  Lapis K, Szende B, Kovacs L, Simon K.
The effect of E-N-trimethyl lysine (TML) treatment on the regeneration of bone marrow and intestinal mucosa in mice.
Exp Pathol.    impact factor:   0
1983;  24(2-3): 97-101

236:  Kozma D, Lapis K, Debreczeni L.
[Danger of liver damage in modern antitubercular treatment]
Prax Klin Pneumol.    impact factor:   0
1983;  37 Suppl 1: 479-81

237:  Slowik F, Gazso L, Pasztor E, Piffko P, Lapis K.
Morphological investigations of mixed pituitary adenomas.
Acta Morphol Hung.    impact factor:   0
1983;  31(4): 353-64

238:  Elek G, Lang I, Szende B, Lapis K.
The effect of E-N-L-trimethyllysine (TML) on the humoral and cellular immune response.
Agents Actions.    impact factor:   0
1982;  12(4): 503-7

239:  Lapis K.
[Newly discovered aspects of tumor metastasis formation]
Orv Hetil.    impact factor:   0
1982;  123(39): 2395-403

240:  Kopper L, Van Hanh T, Lapis K.
Experimental model for liver metastasis formation using Lewis lung tumor.
J Cancer Res Clin Oncol.    impact factor:   0
1982;  103(1): 31-8

241:  Simon K, Lapis K, Khudolei VV, Pliss GB.
[Action of N-dinitrosopiperazine and N-nitrosodiethylamine on aquarium guppies]
Vopr Onkol.    impact factor:   0
1982;  28(6): 45-9

242:  Staub M, Szpaszokukockaja T, Bencsath M, Antoni F, Lapis K.
DNA polymerase and thymidine kinase activities in MC-29 virus-induced transplantable hepatoma and the effect of cytostatic treatment of these activities.
Chem Biol Interact.    impact factor:   0
1982;  41(2): 181-92

243:  Schaff Z, Pohl O, Bencsath M, Brojnas J, Lapis K, Kopper L, Hollos I.
HBsAg-like structures in immunosuppressed mice inoculated with human hepatitis B virus.
Virchows Arch B Cell Pathol Incl Mol Pathol.    impact factor:   0
1982;  40(2): 249-61

244:  Kozma D, Mihalik P, Schaff Z, Lapis K.
[Hepatotoxic action of rifampicin and isonicotinic acid hydrazide]
Probl Tuberk.    impact factor:   0
1982;  (7): 68-72

245:  Kovacs JB, Kovacs L, Lorincz M, Lapis K.
[Results of low-dose gluten loading in the diagnosis of infantile celiac disease]
Orv Hetil.    impact factor:   0
1982;  123(42): 2589-94

246:  Kozma D, Tompa A, Schaff Z, Lapis K.
[The effect of rifampicin and INH on the mouse liver]
Prax Klin Pneumol.    impact factor:   0
1982;  36(10): 429-33

247:  Litmanovich KIu, Lapis GA.
[Compensation for blood loss and the correction of hemostasis in reconstructive operations on the arteries in arteriosclerosis obliterans]
Vestn Khir Im I I Grek.    impact factor:   0
1982;  129(10): 50-5

248:  Lapis KU.
[Clinicopathological aspects of metastasis formation]
Orv Hetil.    impact factor:   0
1982;  123(25): 1533-7

249:  Papaian LP, Fedprova ZD, Shitikova AS, Lapis GA.
[Variants of the course of von Willebrand's disease]
Probl Gematol Pereliv Krovi.    impact factor:   0
1981;  26(11): 45-8

250:  Kopper L, Van Hanh T, Hegedus C, Lapis K.
Growth of human colorectal tumor xenografts in immunosuppressed mice reconstituted with normal cells.
Exp Cell Biol.    impact factor:   0
1981;  49(3): 141-7

251:  Timar J, Kopper L, Lapis K.
Electronmicroscopical detection of iota-carrageenan as its ruthenium red complex.
Histochemistry.    impact factor:   0
1981;  72(1): 101-6

252:  Lapis K, Kopper L, Timar J, van Hanh T, Hegedus C.
Effect of macrophages on the growth of syn- and xenogeneic tumors.
Arch Geschwulstforsch.    impact factor:   0
1981;  51(6): 475-9

253:  Hegedus C, Lapis K.
[Significance of the determination of steroid receptors in breast cancer]
Orv Hetil.    impact factor:   0
1981;  122(12): 685-8U

254:  Banoczy J, Lapis K, Albrecht M.
Scanning electron microscopic study of oral leukoplakia.
J Oral Pathol.    impact factor:   0
1980;  9(3): 145-54

255:  Conti P, Suba Z, Szende B, Lapis K, Takacs J, Elek G.
[E-N-trimethyl-lysine: a natural cellular component with mitogenic activity]
Boll Soc Ital Biol Sper.    impact factor:   0
1980;  56(2): 115-20

256:  Simon K, Tajti L, Lapis K.
Hepatic lesions in Lebistes reticulatus induced by N-nitrosodiethylamine.
IARC Sci Publ.    impact factor:   0
1980;  (31): 717-29

257:  Pauletto P, Pessina AC, Giaroli E, Pagnan A, Mazzucato A, Lapis F, Merigliano S, Abatangelo G.
[Changes of the permeability of the aortic endothelium in renovascular hypertension in the rat (preliminary data)]
Boll Soc Ital Biol Sper.    impact factor:   0
1980;  56(5): 468-73

258:  Szabo Z, Dworak O, Kopper L, Lapis K.
Effect of combined surgical and chemotherapeutic treatment of Lewis lung carcinoma.
J Cancer Res Clin Oncol.    impact factor:   0
1980;  97(2): 161-6

259:  Vidos I, Katona A, Schaff Z, Lapis K.
[Alcoholic fatty liver]
Orv Hetil.    impact factor:   0
1980;  121(21): 1239-42

260:  Kopper L, Lapis K, Hegedus C.
Chemotherapeutic sensitivity of human colorectal tumor xenografts.
Oncology.    impact factor:   0
1980;  37 Suppl 1: 42-50

261:  Csanyi E, Horvath T, Kiraly E, Lapis K, Kopper L.
New type bifunctional nitrosoureido derivatives with cytostatic activity.
Oncology.    impact factor:   0
1980;  37 Suppl 1: 59-66

262:  Lapis K, Timar J, Bencsath M, Van Hanh T, Kopper L.
Cytochemical study of peritoneal macrophages in carrageenan-treated immunosuppressed mice.
Arch Geschwulstforsch.    impact factor:   0
1980;  50(5): 435-42

263:  Beketova TP, Lapis K, Korolev VV, Kovacs L.
[Liver regeneration characteristics in young rats in allyl alcohol lesion of the periportal areas]
Biull Eksp Biol Med.    impact factor:   0
1980;  90(8): 238-42

264:  Elek G, Lapis K, Rockenbauer A.
Electron spin resonance (ESR) spectrum of paraffin embedded human liver tissue. A possible method for the estimation of copper content.
Histochemistry.    impact factor:   0
1979;  61(2): 233-7

265:  Lapis K, Johannessen JV.
Pathology of primary liver cancer.
J Toxicol Environ Health.    impact factor:   0
1979;  5(2-3): 315-55

266:  Lapis K.
Histology and ultrastructural aspects of virus-induced primary liver cancer and transplantable hepatomas of viral origin in chickens.
J Toxicol Environ Health.    impact factor:   0
1979;  5(2-3): 469-501

267:  Prajda N, Eckhardt S, Suba Z, Lapis K.
Biochemical behavior of MC-29 virus-induced transplantable chicken hepatoma.
J Toxicol Environ Health.    impact factor:   0
1979;  5(2-3): 503-8

268:  Jeney A, Kovalszky I, Gyapay G, Lapis K, Suba Z.
Chromatin alterations and gene function disorder in MC-29 virus-derived hepatoma.
J Toxicol Environ Health.    impact factor:   0
1979;  5(2-3): 509-16

269:  Elek G, Lapis K, Foldes I.
Comparative study of tumor-specific transplantation antigens of MC-29 chicken hepatoma and Rous sarcoma virus-induced sarcomas in mice.
J Toxicol Environ Health.    impact factor:   0
1979;  5(2-3): 529-36

270:  Bencsath M, Schaff Z, Lapis K.
Rhizoplat in experimental and human liver tumors.
Acta Biol.    impact factor:   0
1979;  30(4): 393-5

271:  Lapis K.
[Dr. Jozsef Balo (1895-1979)]
Orv Hetil.    impact factor:   0
1979;  120(48): 2902-4

272:  Jakab I, Sreter L, Raposa T, Schranz V, Horvath M, Peterfy M, Graf F, Suba Z, Lapis K.
[Hairy cell leukemia]
Orv Hetil.    impact factor:   0
1979;  120(27): 1607-12

273:  Dziewanowski K, Lapis J, Remigolski L, Sluczanowski W.
[Diagnostic difficulties in cases of acute carbon tetrachloride poisoning]
Wiad Lek.    impact factor:   0
1979;  32(10): 685-9

274:  Jeney A, Dzurillay E, Lapis K, Valko E.
Chromatin proteins as a possible target for antitumour agents: alterations of chromatin proteins in dibromodulcitol treated Yoshida tumors.
Chem Biol Interact.    impact factor:   0
1979;  26(3): 349-61

275:  Timar J, Gyapay G, Lapis K.
Acridine orange staining of the mammalian fibroblast cell coat.
Histochemistry.    impact factor:   0
1979;  64(2): 189-93

276:  Szende B, Gyapay G, Ferencz G, Ujhelyi E, Lapis K, Jeney A.
Spontaneous and chemically-induced transformation of mouse fibroblasts in culture. Biochemical aspects of the transformed cells.
Acta Biol.    impact factor:   0
1979;  30(4): 309-16

277:  Elek G, Lapis K, Rockenbauer A.
Analysis of the electron spin resonance spectrum of human liver tissue embedded in paraffin.
Acta Biochim Biophys Acad Sci Hung.    impact factor:   0
1979;  14(4): 249-58

278:  Lapis JL, Staab EV, Bozymski EM.
An evaluation of ultrasonic pancreatography.
N C Med J.    impact factor:   0
1978;  39(1): 28-30

279:  Buky B, Eszter E, Lapis K, Tulassay T, Szende B.
[Clinical picture and ultrastructural changes in the course of idiopathic respiratory distress syndrome in its various phases]
Orv Hetil.    impact factor:   0
1978;  119(1): 27-30

280:  Kopper L, Lapis K.
[Xenotransplantation of human malignant tumors]
Orv Hetil.    impact factor:   0
1978;  119(9): 533-6

281:  Lapis K, Repasy G, Kiraly K.
The effect of retinoic acid on Lewis lung carcinoma model in mice. A preliminary note.
Dermatologica.    impact factor:   0
1978;  157 Suppl 1: 52-3

282:  Lapis K, Jeney A, Tyihak E, Kopper L, Szarvas T, Bursics L, Ujhelyi E, Szende B.
Studies on the uptake of N-E-3H-trimethyl-L-lysine in the organs of mice with NK/Ly ascites tumors.
Acta Biochim Biophys Acad Sci Hung.    impact factor:   0
1978;  13(1-2): 47-55

283:  Stipovits L, Rashwan A, Takacs J, Lapis K.
Occurrence of ureaplasmas in swine semen.
Zentralbl Veterinarmed [B].    impact factor:   0
1978;  25(7): 605-8

284:  Nemeth L, Lapis K, Kovacs J.
[Galactose metabolism disturbance and small intestine lesions]
Verh Dtsch Ges Pathol.    impact factor:   0
1978;  62: 357

285:  Szende B, Lapis K, Repassy G, Simon K, Besznyak I.
[Specification of the ultrastructure of thymomas]
Verh Dtsch Ges Pathol.    impact factor:   0
1978;  62: 373

286:  Szepeshazi K, Lapis K, Jeney A, Szende B, Schawartz J, Ujhelyi E, Takacs J, Kovalszky I, Tompa A.
Morphological and biochemical studies on the effect of agents with liver protecting properties.
Exp Pathol (Jena).    impact factor:   0
1978;  15(5): 271-87

287:  Schaff Z, Lapis K.
[Significance of virus-like particles in tumors and autoimmune diseases]
Orv Hetil.    impact factor:   0
1977;  118(4): 187-90

288:  Szepeshazi K, Lapis K, Horvath A, Visy M, Schaff Z.
[Incidence of tubuloreticular structures and their significance in human kidney biopsy material]
Orv Hetil.    impact factor:   0
1977;  118(6): 315-8

289:  Elek G, Rockenbauer A, Lapis K.
Electron spin resonance spectra of chicken liver and hepatoma tissue embedded in paraffin.
Acta Biochim Biophys Acad Sci Hung.    impact factor:   0
1977;  12(3): 231-5

290:  Honti J, Lapis K.
[Marek's disease; Jozsef Marke, M.D., internationally known pioneer of experimental oncology]
Orv Hetil.    impact factor:   0
1977;  118(37): 2223-5

291:  Tompa A, Lapis K, Szende B.
Light and electron microscopic study of hermorrhagic hepatitis induced by trimethyllysine and D-galactosamine.
Exp Pathol (Jena).    impact factor:   0
1977;  13(2-3): 118-29

292:  Szeplaki F, Deak BG, Benedeczky I, Lapis K.
[Pheochromocytoma and multiple tumor formation. Ultrastructure of pheochromocytoma]
Orv Hetil.    impact factor:   0
1977;  118(3): 153-5

293:  Horvath A, Schaff Z, Kramer M, Szepeshazi K, Ablonczy E, Bognar A, Kiraly K, Lapis K.
[Clinical significance of tubuloreticular structures in circulating lymphocytes of patients with erythematodes]
Orv Hetil.    impact factor:   0
1977;  118(9): 500-3

294:  Ferencz G, Szende B, Lapis K, Podmaniczky E.
Scanning electron microscopic studies on untreated and transformed mouse embryo fibroblast cell cultures.
Exp Pathol (Jena).    impact factor:   0
1977;  13(4-5): 275-9

295:  Lapis K, Ferencz G, Szende B, Kovalszky I, Jeney A.
In vitro carcinogenesis studies on mouse fibroblast cells.
Acta Biol.    impact factor:   0
1977;  28(3): 247-57

296:  Kopper L, Jeney A, Ferencz G, Lapis K, Szende B.
Studies on in vitro carcinogenesis. I. Autoradiographic and biochemical study on the incorporation of labelled methylcholantrene into mouse embryonic cells.
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol.    impact factor:   0
1976;  85(2): 117-24

297:  Stratton RD, Lapis JL, Bozymski EM.
Pseudomembranous colitis following clindamycin therapy.
N C Med J.    impact factor:   0
1976;  37(3): 141-3

298:  Lapis K.
[Mechanism of the antitumor action of 1,6-di-o-methane-sulfonide-2,3-4,5-dianhydro-1-iditol]
Vopr Onkol.    impact factor:   0
1976;  22(6): 61-71

299:  Besznyak B, Szepeshazi K, Nemes A, Lapis K.
[Castelman tumor]
Orv Hetil.    impact factor:   0
1975;  116(36): 2130-2

300:  Elek G, Lapis K, Rockenbauer A, Tibay T.
Electron spin resonance spectra of chicken hepatoma and liver tissue.
Acta Biochim Biophys Acad Sci Hung.    impact factor:   0
1975;  10(3): 181-4

301:  Lapis K, Schaff Z.
[Current views on the viral origin of cancer]
Orv Hetil.    impact factor:   0
1974;  115(19): 1083-91

302:  Schaff Z, Lapis K, Irene KB.
[The role and possibilities of use of scanning electron microscopy as a new morphologic examination method in medicine]
Orv Hetil.    impact factor:   0
1974;  115(22): 1263-7

303:  Stotz GY, Szende B, Lapis K, Tyihak E.
The effect of epsilon-N-DL-trimethyl-lysine on human lymphocyte cultures.
Exp Pathol (Jena).    impact factor:   0
1974;  9(5-6): 317-22

304:  Schuler D, Lapis K, Borzsonyi M, Machay T, Gorgenyi A.
[Unusual pulmonary complications of acute leukemia in children following complete hematologic remission]
Orv Hetil.    impact factor:   0
1973;  114(35): 2107-11

305:  Kiss J, Kopper L, Lapis K.
Effect of 1,6-dibromodulcitol (DBD) on the RNA metabolism of S37 tumour cells.
Acta Biol.    impact factor:   0
1973;  24(3): 131-5

306:  Lapis K, Jeney A, Kopper L, Szende B, Benedeczky I.
Cell population kinetics, biochemical, ultrastructural changes occurring during growth of experimental tumors and their relevance to cancer chemotherapy.
Arch Geschwulstforsch.    impact factor:   0
1973;  42(3): 229-39

307:  Preston JF, Lapis E, Gander JE.
The appearance of exo- -mannosidase in cultures of Penicillium charlesii.
Arch Mikrobiol.    impact factor:   0
1973;  88(1): 71-6

308:  Lapis J, Synoradzka K.
[Secondary polycythemia in a patient with primary hepatic carcinoma]
Wiad Lek.    impact factor:   0
1972;  25(15): 1369-72

309:  Szende B, Borzsonyi M, Lapis K, Szabo Z, Renyi-Vamos F Jr.
[Ultrastructural changes in the human and dog myocardium following mechanical and electric interventions in resuscitation]
Exp Pathol (Jena).    impact factor:   0
1972;  6(5): 310-24

310:  Szepeshazi K, Lapis K, Miltenyi M, Marosvari I, Beregi E.
Ultrastructural studies in the nephrotic syndrome of childhood.
Int Urol Nephrol.    impact factor:   0
1971;  3(4): 415-28

311:  Szende B, Lapis K, Pinter A, Nemes A, Tarjan E.
[Pneumoconiosis caused by inhalation of polyvinylchloride]
Orv Hetil.    impact factor:   0
1971;  112(2): 85-6

312:  Mester E, Lapis K, Tota JG.
[Ultrastructural changes in Ehrlich ascites tumor cells following laser irradiation]
Arch Geschwulstforsch.    impact factor:   0
1971;  38(3): 210-20

313:  Lapis J, Marlicz K, Wichert K.
[Coma in the course of Addison's anemia]
Przegl Lek.    impact factor:   0
1970;  26(6): 562-3

314:  Fiedorowicz-Fabrycy I, Lapis J.
[Leukomoid reaction: leukemia (?) in the course of tuberculosis]
Przegl Lek.    impact factor:   0
1970;  26(7): 617-9

315:  Lapis J, Fiedorowicz-Fybrycy I.
[Comparison of the nitrite test as modified by Sleigh with TTC test in the diagnosis of urinary tract infections]
Wiad Lek.    impact factor:   0
1969;  22(2): 137-40

316:  Weinstein P, Lapis K.
[Ultrastructure of glaucomatous eyes]
Orv Hetil.    impact factor:   0
1969;  110(2): 65-6

317:  Lapis K.
[The role and importance of lysosomes in pathology]
Orv Hetil.    impact factor:   0
1968;  109(15): 785-97

318:  Korenyi-Both A, Lapis K, Gallai M.
[Fine structure of undifferentiated adult pleomorph rhabdomyosarcoma]
Beitr Pathol Anat.    impact factor:   0
1968;  138(1): 96-108

319:  Benedeczky I, Lapis K.
[Electron microscopy of human adrenal medulla and pheochromocytoma]
Beitr Pathol Anat.    impact factor:   0
1968;  137(4): 403-38

320:  Fiedorowicz-Fabrycy I, Lapis J.
[Poisoning with Gyromitra esculenta]
Wiad Lek.    impact factor:   0
1968;  21(6): 489-91

321:  Fiedorowicz-Fabrycy I, Lapis J, Majewska M, Pilarska K.
Clinical analysis of complications of diabetes in the material of the Departments of Internal Diseases of the Pomeranian Medical Academy in Szczecin.
Pol Med J.    impact factor:   0
1967;  6(2): 339-45

322:  Lapis K, Benedeczky I, Bolla K.
Ultrastructural alterations induced by alkylating agent (R-74) in tumour cells.
Acta Biol.    impact factor:   0
1967;  18(3): 303-22

323:  Both AK, Lapis K, Gallai M.
[On the fine structure of muscular changes in progressive muscular dystrophy]
Beitr Pathol Anat.    impact factor:   0
1967;  135(4): 436-56

324:  Fiedorowicz-Fabrycy I, Lapis J, Majewska M, Pilarska K.
[Clinical analysis of complications of diabetes mellitus in the material in departments of internal medicine of the Pomeranian Academy of Medicine in Szczecin]
Pol Arch Med Wewn.    impact factor:   0
1966;  36(6): 749-55

325:  Kiczak J, Lapis J, Majewska M, Stalewski R, Wichert K.
[Clinical picture of plasmocytoma in the light of 45 cases]
Pol Arch Med Wewn.    impact factor:   0
1966;  36(3): 331-7

326:  Lapis K, Benedeczky I.
Antimetabolite-induced changes in the fine structure of tumour cells.
Acta Biol.    impact factor:   0
1966;  17(2): 199-215

327:  Kiczak J, Lapis J, Wichert K.
[Rendu-Osler-Weber disease (report of a family)]
Pol Arch Med Wewn.    impact factor:   0
1965;  35(10): 1511-4

328:  Lapis K.
Electronmicroscopic examination of KB cell cultures infected with adenovirus type 12.
Acta Microbiol Acad Sci Hung.    impact factor:   0
1965;  12(3): 241-59

 

Responsed in 2046 milliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005